Annual report pursuant to Section 13 and 15(d)

Revenue - Collaboration Agreement - The GSK Collaboration and License Agreement (Details)

v3.20.4
Revenue - Collaboration Agreement - The GSK Collaboration and License Agreement (Details)
12 Months Ended
Dec. 31, 2019
USD ($)
GlaxoSmithKline Intellectual Property Development Ltd | Astellas Collaboration Agreement  
Collaboration and License Agreement  
Amount of development milestone achieved $ 3,200,000